AI-native biotech Proxima raised $80 million in an oversubscribed seed round to develop proximity-based therapeutics. The funding supports AI-driven discovery for previously “undruggable” targets across oncology and immunology.
Biotech startup Chai Discovery raised $130 million in a Series B round at a $1.3 billion valuation to advance AI-driven drug discovery.
March 6th, 2026
March 6th, 2026
March 6th, 2026
March 6th, 2026
March 5th, 2026